Exelixis filed required disclosures regarding share holdings with the Securities and Exchange Commission.

The entities involved

• Exelixis →

  American biotechnology company

  • A collaboration between Bristol-Myers Squibb and Exelixis is seeking FDA clearance for an IND application regarding combination therapies.07:16
  • Exelixis and uniQure N.V. are competing for investment opportunities as healthcare companies.Fri 17:10
• Securities and Exchange Commission →

  government agency of the Philippines

  • Rothschild Wealth LLC purchased a new stake in the Distillate Small/Mid Cash Flow ETF, which subsequently filed required reports with the SEC.05:35
  • Sara Duterte was questioned regarding corporate oversight failures as her corporate role was scrutinized during impeachment proceedings.04:47

Related events

• Millicom International Cellular SA filed disclosures regarding share holdings with the Securities and Exchange Commission on July 25, 2026.Jul 25
• F5, Inc. filed disclosures regarding share purchases with the Securities and Exchange Commission.Sep 11
• Qualcomm filed required disclosures regarding institutional stake purchases with the Securities and Exchange Commission.Jun 19
• Disclosure made to the Securities and Exchange Commission involving Northern Trust on July 2, 2026.Jul 2
• Mary Beckerle is a director of Exelixis, and the SEC is tracking institutional filings regarding the company's stock.Nov 2